GlaxoSmithKline plc CEDEAR (GSKD)
BCBA
Real-time Data
02:00 PM
Day's Range
12.2752 wk Range
10.99Overview - GSKD - GlaxoSmithKline plc CEDEAR
Key Statistics
Valuation
Enterprise Value
54.53B
P/E (Trailing)
‪0.04‬
Price / Book
‪1.10‬
EV / EBITDA
‪3.79‬
Profitability
Profit Margin
‪14.52%‬
Operating Margin
‪30.94%‬
Return on Assets
‪10.00%‬
Return on Equity
‪33.38%‬
Ownership
Float
1.94B
Held by Insiders
‪0.00%‬
Held by Institutions
‪0.00%‬
Price stats
Beta
‪0.29‬
50-Day Avg
‪13.27‬
200-Day Avg
‪13.44‬
Dividends
Frequency
Quarterly
Peers - GSKD - GlaxoSmithKline plc CEDEAR
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on BCBA.
Profile Summary - GSKD - GlaxoSmithKline plc CEDEAR
About
GlaxoSmithKline plc CEDEAR is a depositary receipt representing shares of GlaxoSmithKline plc, a leading global pharmaceutical and healthcare company. CEDEARs (Certificados de Depósito Argentinos) enable Argentine investors to access foreign securities, allowing them to participate in the performance of major…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
